Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 05 entities : Sanofi save search
Tenders for the win: four strategies that will improve your bids
Published: 2021-08-05 (Crawled : 00:00) - modeln.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-05 (Crawled : 22:00) - globenewswire.com
TBIO | $0.302 -8.76% -9.6% 160K
|
Health Technology
|
| O: 0.0%
H: 0.34%
C: -0.03%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
financial results results
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021
Published: 2021-08-05 (Crawled : 21:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: 4.67%
H: 0.7%
C: -0.49%
financial results results
Global $191 Billion Orphan Drugs Markets to 2026: Therapeutic Applications in Rare and Orphan Diseases, Regulatory Framework, Patents, and Innovations
Published: 2021-08-05 (Crawled : 20:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.85%
H: 0.15%
C: -0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.02%
H: 0.09%
C: -1.38%
disease drug patent application rare
Legacy Investing And Invesco Real Estate Expand Data Center Portfolio With Sale-Leaseback Of Flexential's Plano, Texas Facility And Hillsboro 3 Data Center In Portland
Published: 2021-08-05 (Crawled : 18:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
Primary Hyperoxaluria Market Size Growth to Shore Up at a Substantial CAGR of 40.40% During the Study Period 2018-30 in the 7MM | DelveInsight
Published: 2021-08-05 (Crawled : 18:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 1.27%
H: 2.13%
C: 0.88%
IMAB | $1.81 0.56% 0.55% 340K
|
Health Technology
|
| O: -1.28%
H: 5.29%
C: 1.99%
AVXL | News | $3.8 0.0% 2.1M
|
Health Technology
|
| O: 2.8%
H: 8.18%
C: 7.68%
growth
Lung Cancer Drug Candidate Offers Patients Hope for Longer Life
Published: 2021-08-05 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
lung cancer cancer drug
Insights on the Kidney Cancer Diagnostics and Therapeutics Global Market to 2026 - Key Motivators, Restraints and Opportunities
Published: 2021-08-05 (Crawled : 16:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.42%
H: 0.31%
C: 0.13%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.69%
H: 0.37%
C: 0.34%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: 0.0%
H: 2.03%
C: 1.25%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.48%
H: 0.46%
C: 0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.58%
H: 4.05%
C: 2.02%
cancer diagnostics kidney diagnostic
Global Depression Treatment Market (2020 to 2026) - Featuring Allergen, Bausch Health Companies and Lief Therapeutics Among Others
Published: 2021-08-05 (Crawled : 16:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.42%
H: 0.31%
C: 0.13%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -0.09%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.69%
H: 0.37%
C: 0.34%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
GRMN | $139.52 -0.85% 0.0% 2.9M
|
Electronic Technology
|
| O: 0.44%
H: 0.65%
C: 0.55%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.48%
H: 0.46%
C: 0.43%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 1.22%
H: 0.39%
C: -1.17%
treatment depression
Regeneron Reports Second Quarter 2021 Financial and Operating Results
Published: 2021-08-05 (Crawled : 11:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 1.32%
H: 2.47%
C: 2.35%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -2.46%
H: 24.2%
C: 15.24%
results
Phase 3 Trial of Libtayo® (cemiplimab-rwlc) Combined with Chemotherapy Stopped Early Due to Significant Improvement in Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer
Published: 2021-08-05 (Crawled : 11:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 1.32%
H: 2.47%
C: 2.35%
lung cancer therapy cancer phase 3 trial
Phase 3 trial of Libtayo® (cemiplimab) combined with chemotherapy stopped early due to significant improvement in overall survival in patients with first-line advanced non-small cell lung cancer
Published: 2021-08-05 (Crawled : 11:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 1.32%
H: 2.47%
C: 2.35%
lung cancer therapy cancer phase 3 trial
Change to ALK’s Board of Directors
Published: 2021-08-05 (Crawled : 09:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.